ALDX CIK: 1341235

Aldeyra Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−42.6
FY22:
−56.6
FY23:
−30.3
FY24:
−43.2
FY25:
−33.3
Change from FY21 to FY25
millions USD
FY21:
−0.01
FY22:
−30.0
FY23:
30.0
FY24:
−44.9
FY25:
47.7
Change from FY21 to FY25
millions USD
FY21:
194
FY22:
1.22
FY23:
−1.27
FY24:
−0.17
FY25:
1.12
millions USD
FY21:
152
FY22:
−85.4
FY23:
−1.60
FY24:
−88.3
FY25:
15.5
(positive)
Change from FY21 to FY23
millions USD
FY21:
−42.6
FY22:
−56.7
FY23:
−30.3
FY24:
–
FY25:
–

All amounts in millions USD Data source:SEC EDGAR